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Abstract
Background: There has been a recent growth in the use of whole body Computerised Tomography (CT) scans in
the private sector as a screening test for asymptomatic disease. This is despite scant evidence to show any positive
effect on morbidity or mortality. There has been concern raised over the possible harms of the test in terms of
radiation exposure as well as the risk and anxiety of further investigation and treatment for the large numbers of
benign lesions identified.
Case Presentation: A healthy 64 year old lady received a privately funded whole body CT scan for her birthday
which revealed an incidental mass in the right iliac fossa. This was investigated with further imaging and
colonoscopy and as confident diagnosis could not be made, eventually excised. Histology demonstrated this to be
a benign ancient schwannoma and we believe this to be the first reported case of an abdominal wall
schwannoma in the English literature
Conclusions: Ancient schwannomas are rare tumours of the peripheral nerve sheaths more usually found in the
head, neck and flexor surfaces of extremities. They are a subtype of classical schwannomas with a predominance of
degenerative changes. Our case highlights the pitfalls of such screening tests in demonstrating benign disease and
subjecting patients to what turns out to be unnecessary invasive investigation and treatment. It provides evidence
as to the consequences of the large number of false positive results that are created by blind CT scanning of
asymptomatic patients i.e. its tendency to detect pseudodiesease rather than affect survival rates. Should the
number of scans increase there may be an unnecessary burden on NHS resources due to the large numbers of
benign lesions picked up, that are then referred for further investigation.
Background
In recent years private entrepreneurs have recognised,
some might say exploited, a market for radiological
screening tests [1,2]. One of these tests, Computerised
Tomography (CT), in particular whole body CT, is ten-
dered as a possible tool to identify asymptomatic thor-
acic and abdominal disease. However, before any
procedure is adopted to screen for disease, its cost, ben-
efit and risk should all be taken into account and before
this happens the value of the test must remain unproven
and unknown[3] To date, this evaluation has not been
carried out with whole body CT screening in asympto-
matic individuals [4]. This may be due to the huge cost
and long follow up period required for such a trial as
well as the fact that grants are unlikely to be given to
research what is increasingly seen as an entrepreneurial
scheme [2]. Hence, a number of clinical, ethical and
health-economical issues have been raised by medical
professionals in response to the growth of such an
unproven test in the private sector. Although these cen-
tre on the lack of evidence that blind CT scanning of
asymptomatic individuals produces any benefit in terms
of identifying or precluding disease, they also emphasise
the potential harm from radiation as well as from
further, often invasive, investigations which are offered
in the large number of false positive cases frequently
seen. Furthermore, some have voiced concern at the
growing public expenditure spent on investigating the
large number incidental lesions uncovered on private
CT scans. In this paper, we present our treatment for a
lesion identified on a private whole body CT scan, given
to our patient as a birthday present, as well as recount
what we believe to be the first reported case in the
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English literature of an abdominal wall ancient schwan-
noma. We discuss the clinical, histological and radiolo-
gical features of ancient schwannomas, as well as
discuss in further depth, the controversy surrounding
whole body CT screening in asymptomatic individuals.
Case Report
A healthy 64 year old lady received a LifeScan (privately
funded whole body CT scan) for her birthday which
revealed an incidental mass in the right iliac fossa (RIF).
This was investigated further with a colonoscopy which
revealed small benign polyps only. Initially a putative
diagnosis of GastroIntestinal Stromal Tumour (GIST)
was considered and the patient referred to our NHS
Colorectal outpatient clinic.
Clinically, the lady was well with no weight loss, anae-
mia, change in bowel habit or loss of appetite. She com-
plained of RIF discomfort but admitted that this had
only manifested since her CT scan. She was extremely
anxious about her condition and the underlying diagno-
sis. On examination, a non-tender 8 cm mass was palp-
able in the RIF and a routine blood screen was entirely
normal. The case was discussed at the Lower Gastroin-
testinal Multidisciplinary Team (MDT) meeting and it
was agreed that a repeat CT scan with contrast should
be performed. The scan demonstrated a 6 × 5 cm
heterogeneous mass in the RIF adjacent to the perito-
neal wall (Figure 1). No other abnormality was evident
but a normal appendix could not be identified. These
findings were discussed again at the MDT meeting and
a differential diagnosis of mucinous tumour or chronic
mucocele of the appendix was suggested.
The possible diagnoses were discussed with the
patient and after consideration of the risks and benefits,
she agreed to surgery by a laparoscopic approach. At
laparoscopy a 6 × 4 × 3.5 cm extraperitoneal ovoid
nodule was found on the abdominal wall in the RIF. In
light of the unusual appearances, the procedure was
converted to laparotomy but no intra-peritoneal pathol-
ogy was noted. The lesion was excised and sent for his-
tological examination. Macroscopically, it had a solid
cut surface with tan, brown and cream areas and con-
tained a 1.2 cm cyst. Microscopically, it was composed
of hypocellular and hypercellular areas. The hypocellular
areas were oedematous and myxoid, containing chronic
inflammatory cells and spindle cells which were hapha-
zardly arranged, aggregating in areas to form small focal
palisades. The spindle cells showed hyperchromatic and
irregular nuclei although no mitotic figures were seen
(Figures 2 and 3). There were several foci of stromal
hyalinisation and sclerosis, with numerous ectatic blood
vessels. Immunohistochemistry showed that the spindle
Figure 1 Saggital section of CT Abdomen with Contrast. Well circumscribed RIF mass next to anterior abdominal wall.
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cells were strongly positive for S100 protein and a final
diagnosis of benign ancient schwannoma was made.
Postoperatively, the patient recovered well and was dis-
charged 2 days after surgery. She is now asymptomatic.
Conclusions
Ancient schwannomas are rare tumours originating
from Schwann cells in the peripheral nerve sheath [5].
Up to 20% of cases are associated with Neurofibromato-
sis Type 1 [6]. They usually arise in females [7] between
the ages of 20-50 years, [6] with a predilection for the
head, neck and flexor surfaces of extremities [8,9]. How-
ever, there have been sporadic cases of these tumours
arising in the retroperitoneum, pelvis, perineum, adre-
nals, kidneys and even masquerading as an inguinal her-
nia [9-14]. They may be asymptomatic and only found
incidentally on examination or imaging. However, occa-
sionally they produce pressure effects on surrounding
large nerves [15].
Ancient schwannomas are a subtype of classic
schwannomas with a predominance of degenerative
changes including cyst formation, calcification, haemosi-
derin deposition, interstitial fibrosis, and vascular hyaline
degeneration [16]. They show spindle cells with focal
nuclear palisading patterns [6] arranged in distinctive
dense (Antoni A) and loose (Antoni B) areas [6,16].
Usually, connective tissue fragments (Verocay bodies)
and intranuclear vacuoles (lochkern) are present [17-19].
These features may sometimes be seen on CT, which
may demonstrate a well circumscribed, heterogeneous
mass of low density which fits with the microscopic pat-
tern of cellular and hypocellular areas. The term
“ancient” was used as a description for the degenerative
changes apparent on microscopy [20,21] which was
thought to be due to the increasing tumour size causing
vascular insufficiency [22].
There have been less than ten reports in the literature
of malignant lesions arising from schwannomas [23-25]
although some argue that these malignant tumours may
arise de novo [7] rather than having undergone second-
ary anaplastic change [19,26] and that recurrence after
resection may actually be due to incomplete excision
[27].
Schwannomas react strongly with S100 protein and
immunohistochemistry can be used to aid diagnosis and
to differentiate them from malignant peripheral nerve
sheath tumours [24,28,29]. This is especially helpful as
the occasional appearance of hyperchromatic cells and
cytological atypia may lead to diagnostic difficulty
[19,22] especially when fine needle aspiration cytology
(FNAc) is used to make a diagnosis
[5,7,18,21,22,28,30,31] as this technique rarely produces
an adequate enough sample [29]. False positive diagnosis
of malignancy may lead to over treatment with radical
resections being carried out unnecessarily. Together
with the clinical history, the characteristic radiological
findings may help distinguish schwannomas and prevent
unnecessary resection for such a benign condition
[32-34]. However, as in our case, this is rarely possible
and surgical resection is still common [6,27,35,36].
Our case highlights one of the main pitfalls of whole
body CT scan used as a screening method for disease.
This lady suffered considerable mental anguish, endured
extremely invasive procedures and the significant risks
that accompany them, for a condition that may never
have caused any symptoms. Studies have shown that up
to 86% patients who undergo these scans show at least
one abnormal finding and up to 37% of individuals
receive recommendations for further investigation [37].
Figure 2 Microscopic appearance of the lesion. Pronounced
degenerative changes including myxoid stroma, haemorrhage,
conspicuous blood vessels with hyaline thickening of walls and
luminal thrombosis (H&E ×20)
Figure 3 Microscopic appearance of the lesion Focal marked
nuclear pleomorphism, with isolated cells having bizarre
hyperchromatic nuclei (H&E ×60)
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Whether these findings translate into clinical signifi-
cance is doubtful. Given the large number of findings
identified by such a crude test, there have been calls for
guidelines to be drawn up to as to help clinicians decide
which abnormalities warrant further investigation
[38,39]. Although such guidelines may be helpful, this
may be harder for lesions detected on abdominal or pel-
vic CT given that the often non contrast CT method
used for screening, rarely provides enough detailed
information on which to guide management. Addition-
ally, different guidelines would have to be drawn up for
different organs. Yet this would have been of little bene-
fit in our case as the lesion was adherent to the anterior
abdominal wall. In spite of this, the few supporters of
screening CT do point out that as with mammograms,
false positive results may decrease with increased use
and experience of the test [40].
As well as the high false positive rate, the other main
criticism levelled is that there is scant evidence that
whole body CT reduces morbidity or mortality [2] even
if it were to correctly identify true positives or negatives.
For example, lead time bias may mean earlier diagnosis
of disease but not improved survival. Length bias may
mean overrepresented diagnoses of slower progressing
disease (more likely to be picked up by a static screen-
ing test such as a CT scan) but again not actually
improved survival times. Overdiagnosis bias (demon-
strated effectively in our case) occurs when pseudodie-
sease- i.e. cases that probably wouldn’t have caused
disease were they not picked up, is not adjusted for [41].
True negative results would of course reassure indivi-
duals, however this may lead them carrying on with
unhealthy lifestyle habits in the knowledge that they
have been given the “all clear”. Of course, false negatives
are probably the worst outcomes for both the patient
and reporting radiologist [2].
Given the lack of evidence of any tangible benefit of
CT screening tests, some have speculated they may
actually do more harm than good. There is an ongoing
debate as to whether the risks of radiation from whole
body CT may be harmful to asymptomatic individuals
and differences stem from the calculation of radiation
dose depending on type of scanner and protocol used or
whether interval CT scans are offered [42,43]. Although
it is hard to prove these associations, given that we are
cautious with regards to radiation exposure in our usual
practice it seems prudent to apply the same hesitancy
when it comes to unproven screening tests.
But what for the argument that CT screening tests
offer individuals control over their own healthcare for
those that can afford it? Although patients who present
for these tests may value the consumer empowerment
over their healthcare management and desire “compre-
hensive wellness” (i.e. assurance that they are free of
disease even in the absence of symptoms), [44] one has
to remember that CT screening may have a large false
positive rate and as in our report, the costs of the addi-
tional investigations will mostly be borne by the NHS,
despite the initial screening test being performed in the
private sector. There is concern that should CT screen-
ing become more widespread, the financial burden of
distinguishing the incidentalomas from true disease be
may end up being shared by the taxpayer and thereby
increase national health expenditure [1,44] hence widen-
ing the disparity of healthcare options for the less well-
off [44]. Of course this is an argument that may be
made of other unproven treatments performed only in
the private sector. However the targeted marketing of
CT screening to the asymptomatic, economically com-
fortable and educated health conscious consumer [45]
as well as the prima fasciae logic embedded such a test
should the benefits and risks not be adequately
explained, brings the potential for a huge number of
“worried well” presenting to publicly funded surgical
outpatients clinics.
In this study we have presented the first reported case
in the English literature of an abdominal wall ancient
schwannoma and discussed the key clinical, radiological
and pathological features of the condition. As this was
picked up asymptomatically on a private health whole
body CT screen given to the patient as a birthday pre-
sent, we have extolled the pitfalls of such tests as well as
offered an insight into the clinical, ethical and health
economic issues that they raise. Wider marketing and
availability of these services may lead to increased non
evidence based patient-led screening in the private sec-
tor. Unfortunately, this may add an unnecessary burden
to public health resources.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompany-
ing images. A copy of the written consent is available
for review by the Editor-in-Chief of this journal.
Acknowledgements
The authors would like to thank the patient for allowing us to share her
case in a medical journal. Written consent was obtained from the patient for
publication of study
Author details
1General Surgical Department, Basildon and Thurrock University Hospital
Trust, Room B208, Nethermayne, Essex, SS16 5NL, UK. 2Pathology
Department, Basildon and Thurrock University Hospital Trust, Nethermayne,
Essex, SS16 5NL, UK.
Authors’ contributions
RKB was the principal author of the paper, carried out a literature review of
the topic and produced the original manuscript. AB modified this. MR proof
read the document and provided the pathological slides for inclusion into
Bhatia et al. BMC Surgery 2010, 10:1
http://www.biomedcentral.com/1471-2482/10/1
Page 4 of 5
the manuscript. BEL gave final approval for the manuscript to be submitted.
All authors read and approved the final manuscript.
Author information
RKB is a house officer in General Surgery. BEL is a Consultant Surgeon. AB
and MR are Specialist Registrars in General Surgery and Pathology
respectively.
Competing interests
The authors declare that they have no conflicts of interest. The authors
alone are responsible for the content and writing of this paper
Received: 13 July 2009
Accepted: 6 January 2010 Published: 6 January 2010
References
1. Fenton JJ, Deyo RA: Patient Self-Referral for Radiological Screening Tests:
Clinical and Ethical Concerns. Journal of the American Board of Family
Practitioners 2003, 16(6):494-501.
2. Dixon AK: Whole body CT Screening. British Journal of Radiology 2004, , 77:
370-371.
3. Rogers LF: Whole Body CT Screening: Edging towards commerce.
American Journal of Roentgenology 2002, 179:823-824.
4. Anderiesz C, Elwood JM, McAvoy BR, Kenny LM: Whole body CT
Screening: looking for trouble?. Medical Journal of Australia 2004,
181(6):295-296.
5. Hajdu S: Peripheral nerve sheath tumors histiogenesis, classification, and
prognosis. Cancer 72(1):3549-3552.
6. Theodosopoulos T, Stafyla VK, Tsiantoula PK: Special problems
encountering surgical management of large retroperitoneal
schwannomas. World Journal of Surgical Oncology 2008, , 6: 107.
7. White W, Shiu MH, Rosenblum MK, Erlandson RA, Woodruff JM: Cellular
schwannoma: A clinicopathological study of 57 patients and 58 tumors.
Cancer 1990, 66(6):1266-75.
8. Ishihara T, Ono T: Degenerated neurilemoma (ancient schwannoma).
Journal of Dermatology 2001, 28(4):221-225.
9. El-Barhawy M, Khoubehi B, Hrouda D: Perirenal schwannoma: a case
report. Journal of Medical Case Reports 2008, 2:189-194.
10. Ninos A, Douridas G, Liapi G: Schwannoma in the inguinal canal
masquerading an inguinal hernia. Hernia 2004, 8(1):73-5.
11. Tsimoyiannis E, Zagaliki A, Demou A, et al: Pelvic retroperitoneal
schwannoma presenting as a gynaecological mass: Case report.
European Journal of Gynaecological Oncology 2005, 26(1):117-119.
12. Santiago C, Lucha P: Atypical presentation of a rectorectal ancient
schwannoma: A case report and review of the literature. Military medicine
2008, 173(8):814-6.
13. Pante S, Terranova ML, Leonello G, et al: Perineal Schwannoma. Canadian
Journal of Surgery 2009, 52(1):E8-E9.
14. Choudry HA, Nikfarjam M, Liang JJ: Diagnosis and management of
retroperitoneal ancient schwannomas. World Journal of Surgical Oncology
2009, 7:12.
15. Hide I: Giant ancient schwannoma of the pelvis. Skeletal Radiology 2000,
29(9):538-542.
16. Giglio M, Giasotto V, Medica1 M, et al: Retroperitoneal ancient
schwannoma: case report and analysis of clinico-radiological findings.
Annuls of Urology 2002, 36:104-6.
17. Dahl I: Ancient neurilemoma (schwannoma). Acta Pathologica et
Microbiologica Scandinavica Section Pathology 1977, 85(6):812-8.
18. Klijanienko J, Caillaud JM, Lagace R: Cytohistologic Correlations in
Schwannomas (Neurilemoma) including “Ancient,” Cellular, and
Epitheloid Variants. Diagnostic Cytopathology 34(8):517-522.
19. Woodruff JM: The Pathology and Treatment of Peripheral Nerve Tumors
and Tumor Like Conditions. Cancer Journal for Clinicians 1993, 43:290-308.
20. Ackerman LV, Taylor FH: Neurogenous tumours within the thorax: a
clinicopathological evaluation of forty-eight cases. Cancer 1951, 4(4):669-
91.
21. Dodd LG, Marom EM, Dash RC, et al: Fine-Needle Aspiration Cytology of
“Ancient” Schwannoma. Diagnostic Cytopathology 20(5):307-311.
22. Argeny ZB, Balogh K, Abraham AA: Degenerative ("ancient”) changes in
benign cutaneous schwannoma: A light microscopic, histochemical and
immunohistochemical study. Journal of Cutaneous Pathology 1993, 20:148-
153.
23. Rasbridge SA, Browse NL, Tighe JR, et al: Malignant nerve sheath tumour
arising in a benign ancient schwannoma. Histopathology 14(5):525-528.
24. Mikami Y, Hidaka T, Akisada T: Malignant peripheral nerve sheath tumor
arising in benign ancient schwannoma: A case report with an
immunohistochemical study. Pathology International 2000, 50:156-161.
25. Yousem SA, Colby T, Urich H: Malignant Epithelial Schwannoma arising in
a benign Schwannoma: A Case report. Cancer 1985, 55:2799-2803.
26. Trojanowski JQ, Kleinman GM, Proppe KH: Malignant Tumors of Nerve
Sheath Origin. Cancer 1980, 46:1202-1212.
27. Rogatsch H, Bartsch G, Stenzi A: Treatment of giant ancient pelvic
schwannoma. Techniques in Urology 2001, 7(4):296-298.
28. McGee RS, Ward WS, Kilpatrick SE: Malignant Peripheral Nerve Sheath
Tumor: A Fine-Needle Aspiration Biopsy Study. Diagnostic Cytopathology
17(4):298-305.
29. Domanski HA, Akerman M, Engellau J, et al: Fine-Needle Aspiration of
Neurilemoma (Schwannoma). A Clinicocytopathologic Study of 116
Patients. Diagnostic Cytopathology 34(6):403-412.
30. Ryd W, Mugal S, Ayyash K: Ancient Neurilemoma: A Pitfall in the
Cytologic Diagnosis of Soft-Tissue Tumors. Diagnostic Cytopathology 1986,
2(3):244-247.
31. Jakowski JD, Wakely PE, Jimenez RE: An uncommon type of adrenal
incidentaloma: a case report of a schwannoma of the adrenal medulla
with cytological, histological, and ultrastructural correlation. Annals of
Diagnostic Pathology 2008, 12:356-361.
32. Loke TKL, Yuen NWF, Lo KKL: Retroperitoneal ancient schwannoma:
Review of the clinico-radiological features. Australian Radiology 1998,
42(2):136-138.
33. Takeuchi M: Ancient schwannoma of the female pelvis. Additional
Imaging 2008, 33(2):247-252.
34. Hennigan TW, Branfoot AC, Theodorou NA: Ancient neurilemoma of the
pelvis. Journal of the Royal Society of Medicine 1992, 85:416-417.
35. Su CM, Li CC, Wang HJ: Hand assisted laparoscopic resection of a
retroperitoneal schwannoma: A case report. Formosan Journal of Surgery
2003, 36(1):25-28.
36. Yoshino T, Yoneda K: Laparoscopic resection of a retroperitoneal ancient
schwannoma: a case report and review of the literature. Anticancer
Research 2008, 28(5B):2889-2891.
37. Furtado CD, Aguirre DA, Dang D, et al: Whole Body CT Screening:
Spectrum of Findings and Recommendations in 1192 Patients. Radiology
2005, 237:385-394.
38. Hall F: Letters to the Editor: Callback and Follow up Guidance for Whole
Body CT Screening. Radiology 2006, 241(2):627-628.
39. Mac Mohan H, Austin JHM, Gamsu G, et al: Guidelines for the
management of small pulmonary nodules detected on CT Scans: a
statement from the Fleischner Society. Radiology 2005, 237:395-400.
40. Hall FM: Letters: CT Screening Examinations. American Journal of
Roentgenology 2003, , 180: 1178-1179.
41. Modic MT, Obuchowski N: Whole body CT screening for cancer and
coronary disease: Does it pass the test?. Cleveland Clinic Journal of
Medicine 2004, 71(1):47-56.
42. Brener DJ, Elliston CD: Estimated Radiation Risks Potentially Associated
with Full Body Screening. Radiology 2004, 232:735-738.
43. Twombly R: Full Body CT Screening: Preventing or Producing Cancer.
Journal of the National Cancer Institute 2004, 96(24):1650-1651.
44. Kolber CT, Zipp G, Glendinning D, Mitchell JJ: Patient Expectations of Full
Body CT Screening. American Journal of Roentgenology 2007, 188:W297-
W304.
45. Illes J, Fan E, Koenig BA, et al: Self Referred Whole Body CT Imaging:
Current Implications for Health Care Consumers. Radiology 2003, 228:246-
351.
Pre-publication history
The pre-publication history for this paper can be accessed here:http://www.
biomedcentral.com/1471-2482/10/1/prepub
doi:10.1186/1471-2482-10-1
Cite this article as: Bhatia et al.: Benign Ancient Schwannoma of the
abdominal wall: An unwanted birthday present. BMC Surgery 2010 10:1.
Bhatia et al. BMC Surgery 2010, 10:1
http://www.biomedcentral.com/1471-2482/10/1
Page 5 of 5
